OSMITROL Mannitol 100g/L injection AHB3026 Australia - English - Department of Health (Therapeutic Goods Administration)

osmitrol mannitol 100g/l injection ahb3026

baxter healthcare pty ltd - mannitol, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.

Mannitol 15% w/v solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

mannitol 15% w/v solution for infusion

baxter holding b.v. - mannitol - solution for infusion - 15 percent weight/volume - solutions producing osmotic diuresis; mannitol

MANNITOL INTRAVENOUS INFUSION BP 20% W/V Kenya - English - Pharmacy and Poisons Board

mannitol intravenous infusion bp 20% w/v

medisel kenya ltd p.o box 540-01000, thika - mannitol bp - infusion - mannitol bp 20 gm - mannitol

MANNITOL Ireland - English - HPRA (Health Products Regulatory Authority)

mannitol

baxter healthcare limited - mannitol - solution for infusion - 15 %w/v - mannitol

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

Mannitol Intravenous Infusion BP 20% w/v Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

mannitol intravenous infusion bp 20% w/v solution for infusion

baxter healthcare limited - mannitol - solution for infusion - 20 percent weight/volume - solutions producing osmotic diuresis; mannitol

MANNITOLVIOSER SOLUTION FOR INFUSION 20 % Israel - English - Ministry of Health

mannitolvioser solution for infusion 20 %

eldan electronic instruments co ltd, israel - mannitol - solution for infusion - mannitol 200 mg/ml - mannitol - mannitol 20%, solution for infusion is indicated for: - the promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; - the reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass; - the reduction of elevated intraocular pressure when the pressure cannot be lowered by other means, and promoting the urinary excretion of toxic substances

Mannitol 75g/500ml (15%) infusion Viaflo bags United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mannitol 75g/500ml (15%) infusion viaflo bags

15%) infusion viaflo bags (baxter healthcare ltd - mannitol - infusion - 150mg/1ml

OSMITROL Mannitol 100g/500mL injection AHB3025 Australia - English - Department of Health (Therapeutic Goods Administration)

osmitrol mannitol 100g/500ml injection ahb3025

baxter healthcare pty ltd - mannitol, quantity: 200 g/l - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.